FindTrial
Sign In

A study analyze the effect of addition of endoscope to microscopic tympanomastoid exploration in case of Chronic Otitis Media (Squamous) disease and evaluate its outcome

A study to evaluate effect after addition of endoscope to microscopic tympanomastoid exploration for chronic otitis media squamous (active)- a randomised control trial - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056627
Enrollment
60
Registered
2023-08-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H719- Unspecified cholesteatoma

Interventions

Intervention1: Group B- Tympanomastoid exploration with microscope and intra operative endoscope assistance: Patients diagnosed as a case of Chronic Otitis Media Squamous (active) with intact posterio

Sponsors

Armed Forces Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All consenting patients with Chronic Otitis Media Squamous (active) with involvement of more than 1 site as per STAM CO classification

Exclusion criteria

Exclusion criteria: a. Patients with Chronic Otitis Media Squamous (Inactive) b. Patients with complications of Chronic Otitis Media Squamous c. Patients with posterior canal wall erosion

Design outcomes

Primary

MeasureTime frame
To evaluate effect of addition of endoscope to microscopic surgery in terms of visualization of difficult areas, disease clearance from difficult areas and preservation of normal anatomyTimepoint: Intraoperative—

Secondary

MeasureTime frame
To evaluate functional outcomes in terms of disease progression and audiological resultsTimepoint: 3 months—

Countries

India

Contacts

Public ContactAbhishek Patel

Armed Forces Medical College

kpsingh_81@yahoo.com9341709008

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026